Health ❯ Healthcare ❯ Clinical Trials
Immunotherapy Glioblastoma Lung Cancer Survival Rates Prostate Cancer Breast Cancer Therapeutic Innovations Personalized Medicine Small Cell Lung Cancer Melanoma Trials
The company plans a Phase 2b trial combining Namodenoson with chemotherapy to test preclinical evidence that the drug increases tumor chemosensitivity.